Efficacy and Safety of Sodium Zirconium Cyclosilicate for Treatment of Hyperkalemia: An 11-Month Open-Label Extension of HARMONIZE
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Efficacy and Safety of Sodium Zirconium Cyclosilicate for Treatment of Hyperkalemia: An 11-Month Open-Label Extension of HARMONIZE ; volume:50 ; number:6 ; year:2019 ; pages:473-480
American journal of nephrology ; 50, Heft 6 (2019), 473-480
- Creator
-
Roger, Simon D.
Spinowitz, Bruce S.
Lerma, Edgar V.
Singh, Bhupinder
Packham, David K.
Al-Shurbaji, Ayman
Kosiborod, Mikhail
- DOI
-
10.1159/000504078
- URN
-
urn:nbn:de:101:1-2019121823571825392281
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Roger, Simon D.
- Spinowitz, Bruce S.
- Lerma, Edgar V.
- Singh, Bhupinder
- Packham, David K.
- Al-Shurbaji, Ayman
- Kosiborod, Mikhail
Other Objects (12)
The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study
Mavoglurant in Fragile X Syndrome: Results of two open-label, extension trials in adults and adolescents
Maintenance of effect of duloxetine in Chinese patients with pain due to osteoarthritis: 13-week open-label extension data
Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: results of a two-year open-label extension trial
Lanreotide autogel/depot in advanced enteropancreatic neuroendocrine tumours: final results of the CLARINET open-label extension study
Ralinepag Phase II Open-Label Extension Study in Patients with Pulmonary Arterial Hypertension
Sustained effect of prasinezumab on Parkinson’s disease motor progression in the open-label extension of the PASADENA trial
Long-term efficacy and safety from an open-label extension of adjunctive cenobamate in patients with uncontrolled focal seizures
Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update
Effects of practicing yoga on alexisomia: an open-label trial
A phase 3 multicenter open-label maintenance study to investigate the long-term safety of sodium zirconium cyclosilicate in Japanese subjects with hyperkalemia
Oral Treprostinil is Associated with Improved Survival in FREEDOM-EV and its Open-Label Extension
The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study
Mavoglurant in Fragile X Syndrome: Results of two open-label, extension trials in adults and adolescents
Maintenance of effect of duloxetine in Chinese patients with pain due to osteoarthritis: 13-week open-label extension data
Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: results of a two-year open-label extension trial
Lanreotide autogel/depot in advanced enteropancreatic neuroendocrine tumours: final results of the CLARINET open-label extension study
Ralinepag Phase II Open-Label Extension Study in Patients with Pulmonary Arterial Hypertension
Sustained effect of prasinezumab on Parkinson’s disease motor progression in the open-label extension of the PASADENA trial
Long-term efficacy and safety from an open-label extension of adjunctive cenobamate in patients with uncontrolled focal seizures
Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update
Effects of practicing yoga on alexisomia: an open-label trial
A phase 3 multicenter open-label maintenance study to investigate the long-term safety of sodium zirconium cyclosilicate in Japanese subjects with hyperkalemia
Oral Treprostinil is Associated with Improved Survival in FREEDOM-EV and its Open-Label Extension
The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study
Mavoglurant in Fragile X Syndrome: Results of two open-label, extension trials in adults and adolescents
Maintenance of effect of duloxetine in Chinese patients with pain due to osteoarthritis: 13-week open-label extension data
Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: results of a two-year open-label extension trial
Lanreotide autogel/depot in advanced enteropancreatic neuroendocrine tumours: final results of the CLARINET open-label extension study
Ralinepag Phase II Open-Label Extension Study in Patients with Pulmonary Arterial Hypertension
Sustained effect of prasinezumab on Parkinson’s disease motor progression in the open-label extension of the PASADENA trial
Long-term efficacy and safety from an open-label extension of adjunctive cenobamate in patients with uncontrolled focal seizures
Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update
Effects of practicing yoga on alexisomia: an open-label trial
A phase 3 multicenter open-label maintenance study to investigate the long-term safety of sodium zirconium cyclosilicate in Japanese subjects with hyperkalemia